Caracciolo, M.; Castello, A.; Urso, L.; Borgia, F.; Marzola, M.C.; Uccelli, L.; Cittanti, C.; Bartolomei, M.; Castellani, M.; Lopci, E.
Comparison of MRI vs. [18F]FDG PET/CT for Treatment Response Evaluation of Primary Breast Cancer after Neoadjuvant Chemotherapy: Literature Review and Future Perspectives. J. Clin. Med. 2023, 12, 5355.
https://doi.org/10.3390/jcm12165355
AMA Style
Caracciolo M, Castello A, Urso L, Borgia F, Marzola MC, Uccelli L, Cittanti C, Bartolomei M, Castellani M, Lopci E.
Comparison of MRI vs. [18F]FDG PET/CT for Treatment Response Evaluation of Primary Breast Cancer after Neoadjuvant Chemotherapy: Literature Review and Future Perspectives. Journal of Clinical Medicine. 2023; 12(16):5355.
https://doi.org/10.3390/jcm12165355
Chicago/Turabian Style
Caracciolo, Matteo, Angelo Castello, Luca Urso, Francesca Borgia, Maria Cristina Marzola, Licia Uccelli, Corrado Cittanti, Mirco Bartolomei, Massimo Castellani, and Egesta Lopci.
2023. "Comparison of MRI vs. [18F]FDG PET/CT for Treatment Response Evaluation of Primary Breast Cancer after Neoadjuvant Chemotherapy: Literature Review and Future Perspectives" Journal of Clinical Medicine 12, no. 16: 5355.
https://doi.org/10.3390/jcm12165355
APA Style
Caracciolo, M., Castello, A., Urso, L., Borgia, F., Marzola, M. C., Uccelli, L., Cittanti, C., Bartolomei, M., Castellani, M., & Lopci, E.
(2023). Comparison of MRI vs. [18F]FDG PET/CT for Treatment Response Evaluation of Primary Breast Cancer after Neoadjuvant Chemotherapy: Literature Review and Future Perspectives. Journal of Clinical Medicine, 12(16), 5355.
https://doi.org/10.3390/jcm12165355
